Vimentin 抗体
(Vimentin (VIM))
This gene encodes a member of the intermediate filament family. Intermediate filamentents, along with microtubules and actin microfilaments, make up the cytoskeleton. The protein encoded by this gene is responsible for maintaining cell shape, integrity of the cytoplasm, and stabilizing cytoskeletal interactions. It is also involved in the immune response, and controls the transport of low-density lipoprotein (LDL)-derived cholesterol from a lysosome to the site of esterification. It functions as an organizer of a number of critical proteins involved in attachment, migration, and cell signaling. Mutations in this gene causes a dominant, pulverulent cataract.[provided by RefSeq, Jun 2009].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| Vimentin 抗体 (AA 371-466) | 人 | 兔 Polyclonal |
|
|
|
| Vimentin 抗体 | 人 | 兔 Polyclonal |
|
|
|
| Vimentin 抗体 (C-Term) | 人, 大鼠, 小鼠 | 兔 Polyclonal |
|
|
|
| Vimentin 抗体 | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| Vimentin 抗体 (AA 1-200) | 人 | 兔 Polyclonal |
|
|
|
| Vimentin 抗体 | 哺乳动物 | 小鼠 Monoclonal |
|
|
|
| Vimentin 抗体 | 人, 大鼠, 小鼠, Pig, 小鸡 | 小鼠 Monoclonal |
|
|
|
| Vimentin 抗体 | 人, Pig, Cow, 小鸡, 犬, Cat, 山羊 | 小鼠 Monoclonal |
|
|
|
| Recombinant Vimentin 抗体 | 人, Pig, Cow, 小鸡, 犬, Cat, 马 | 兔 Monoclonal |
|
|
|
| Recombinant Vimentin 抗体 (AA 325-375) | 人, 小鼠 | 兔 Monoclonal |
|
|
|
| Vimentin 抗体 (AA 2-466) | 人, 大鼠, 小鼠 | 小鼠 Monoclonal |
|
|
|
| Vimentin 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| Vimentin 抗体 (AA 210-466) | 人 | 小鼠 Monoclonal |
|
|
|
| Vimentin 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| Vimentin 抗体 (AA 41-140) | 人 | 小鼠 Monoclonal |
|
|
|
| Vimentin 抗体 (AA 2-466) | 人 | 小鼠 Monoclonal |
|
|
|
| Vimentin 抗体 (AA 152-181) | 人 | 兔 Polyclonal |
|
|
|
| Vimentin 抗体 (AA 1-101) | 人 | 兔 Polyclonal |
|
|
|
| Vimentin 抗体 (full length) | 人 | 小鼠 Monoclonal |
|
|
|
| Vimentin 抗体 (AA 63-90) | 人, 小鼠 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- IF (cc) (Immunofluorescence (Cultured Cells): 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
51 references
KO 验证
- 质量等级
- KO Validated
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 371-466
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- IP (Immunoprecipitation: 有验证图片)
- IF (cc) (Immunofluorescence (Cultured Cells): 有验证图片)
- ELISA (ELISA: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
17 references
KO 验证
- 质量等级
- KO Validated
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB41034
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-200
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- ICC (Immunocytochemistry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- IP (Immunoprecipitation: 有验证图片)
- 适用
- 哺乳动物
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- VI-01
- 标记
- unconjugated
- 抗体亚型
- IgM
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- ICC (Immunocytochemistry: 有验证图片)
- IP (Immunoprecipitation: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- 适用
- 人, 大鼠, 小鼠, Pig, 小鸡
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- VI-10
- 标记
- unconjugated
- 抗体亚型
- IgM
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- PAr (Protein Array: 有验证图片)
- SDS (SDS-PAGE: 有验证图片)
- 适用
- 人, Pig, Cow, 小鸡, 犬, Cat, 山羊
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- VM452
- 标记
- unconjugated
- 抗体亚型
- IgG1
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- SDS (SDS-PAGE: 有验证图片)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, Pig, Cow, 小鸡, 犬, Cat, 马
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- VIM-1937R
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG, kappa
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ICC (Immunocytochemistry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- BLR100G
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
- 抗原表位
- AA 325-375
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 3A1F2
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- AA 2-466
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB16691
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 430-457, C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 5D7
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- AA 210-466
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- C12
- 标记
- unconjugated
- 抗体亚型
- IgG2a kappa
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- IP (Immunoprecipitation: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 3E9
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- AA 41-140
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- PAr (Protein Array: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- VIM-3736
- 标记
- unconjugated
- 抗体亚型
- IgG2b, kappa
- 抗原表位
- AA 2-466
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB15676
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 152-181
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-101
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- ELISA (ELISA: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- VI-RE-1
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- full length
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB15215
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 63-90
Latest Publications for our Vimentin 抗体
: "Topology-optimized melt-electrowritten PCL patch for abdominal wall reconstruction." in: Bioactive materials, Vol. 55, pp. 529-545, (2025) (PubMed).
: "Characterization of the prognostic values and response to immunotherapy/chemotherapy of Krüppel-like factors in prostate cancer." in: Journal of cellular and molecular medicine, Vol. 24, Issue 10, pp. 5797-5810, (2021) (PubMed).
: "Hic-5 deficiency protects cerulein-induced chronic pancreatitis via down-regulation of the NF-κB (p65)/IL-6 signalling pathway." in: Journal of cellular and molecular medicine, Vol. 24, Issue 2, pp. 1488-1503, (2021) (PubMed).
: "ERO1L Promotes Hepatic Metastasis through Activating Epithelial-Mesenchymal Transition (EMT) in Pancreatic Cancer." in: Journal of immunology research, Vol. 2021, pp. 5553425, (2021) (PubMed).
: "Deciphering cell lineage specification of human lung adenocarcinoma with single-cell RNA sequencing." in: Nature communications, Vol. 12, Issue 1, pp. 6500, (2021) (PubMed).
: "Biejiajian Pill Inhibits Carcinogenesis and Metastasis via the Akt/GSK-3β/Snail Signaling Pathway in Hepatocellular Carcinoma." in: Frontiers in pharmacology, Vol. 12, pp. 610158, (2021) (PubMed).
: "Bioinformatics analysis of LINC01554 and its co‑expressed genes in hepatocellular carcinoma." in: Oncology reports, Vol. 44, Issue 5, pp. 2185-2197, (2021) (PubMed).
: "Biological Landscape of Triple Negative Breast Cancers Expressing CTLA-4. ..." in: Frontiers in oncology, Vol. 10, pp. 1206, (2020) (PubMed).
: "Age-Dependent Heterogeneity of Murine Olfactory Bulb Astrocytes." in: Frontiers in aging neuroscience, Vol. 12, pp. 172, (2020) (PubMed).
: "Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity." in: Journal for immunotherapy of cancer, Vol. 8, Issue 1, (2020) (PubMed).
: "Characterization of the prognostic values and response to immunotherapy/chemotherapy of Krüppel-like factors in prostate cancer." in: Journal of cellular and molecular medicine, Vol. 24, Issue 10, pp. 5797-5810, (2021) (PubMed).
: "Hic-5 deficiency protects cerulein-induced chronic pancreatitis via down-regulation of the NF-κB (p65)/IL-6 signalling pathway." in: Journal of cellular and molecular medicine, Vol. 24, Issue 2, pp. 1488-1503, (2021) (PubMed).
: "ERO1L Promotes Hepatic Metastasis through Activating Epithelial-Mesenchymal Transition (EMT) in Pancreatic Cancer." in: Journal of immunology research, Vol. 2021, pp. 5553425, (2021) (PubMed).
: "Deciphering cell lineage specification of human lung adenocarcinoma with single-cell RNA sequencing." in: Nature communications, Vol. 12, Issue 1, pp. 6500, (2021) (PubMed).
: "Biejiajian Pill Inhibits Carcinogenesis and Metastasis via the Akt/GSK-3β/Snail Signaling Pathway in Hepatocellular Carcinoma." in: Frontiers in pharmacology, Vol. 12, pp. 610158, (2021) (PubMed).
: "Bioinformatics analysis of LINC01554 and its co‑expressed genes in hepatocellular carcinoma." in: Oncology reports, Vol. 44, Issue 5, pp. 2185-2197, (2021) (PubMed).
: "Biological Landscape of Triple Negative Breast Cancers Expressing CTLA-4. ..." in: Frontiers in oncology, Vol. 10, pp. 1206, (2020) (PubMed).
: "Age-Dependent Heterogeneity of Murine Olfactory Bulb Astrocytes." in: Frontiers in aging neuroscience, Vol. 12, pp. 172, (2020) (PubMed).
: "Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity." in: Journal for immunotherapy of cancer, Vol. 8, Issue 1, (2020) (PubMed).
Aliases for Vimentin 抗体
vimentin (VIM) 抗体vimentin (Vim) 抗体
vimentin (vim) 抗体
vimentin L homeolog (vim.L) 抗体
vimentin S homeolog (vim.S) 抗体
cb28 抗体
CTRCT30 抗体
vim 抗体
VIM 抗体
vim1 抗体
vim2 抗体
vim4 抗体
vime 抗体
Vimentin 抗体
您还需要查找其他产品吗？
- Villin 1 抗体
- VILL 抗体
- VHLL 抗体
- VHL 抗体
- VGLL4 抗体
- VGLL3 抗体
- VGLL1 抗体
- VGF 抗体
- VEZT 抗体
- VEZF1 抗体
- Vestigial Like 2 抗体
- Vestigial 抗体
- Vesicle-Associated Membrane Protein 1 (Synaptobrevin 1) 抗体
- Vesicle Transport Protein SFT2B 抗体
- Very Low Density Lipoprotein 抗体
- VENTX 抗体
- Ventral Anterior Homeobox 1 抗体
- VEGFR2/CD309 抗体
- VEGFD 抗体
- VEGFC 抗体
You are here:
